Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07641361 · ClinicalTrials.gov registry record · NA
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
A NA study, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07641361 is a NA study that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants.
The verdict
NCT07641361, a NA study, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting to assess feasibility and preliminary efficacy of the intervention through examining participant retention, participant feedback, researcher and participant adherence to protocols, impact on hydration biomarkers, and participant reported GLP - 1 RA side effects.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Hydration Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07641361
The ClinicalTrials.gov registry entry for NCT07641361 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07641361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07641361 about?
NCT07641361 is a clinical study titled "Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy". This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side ...
What is the current status of trial NCT07641361?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-06-15. Estimated completion is 2027-02-01.
What interventions are being tested in trial NCT07641361?
The interventions under investigation include: Control (BEHAVIORAL), Hydration Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT07641361?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.